Company timelines indicate announcements of multiple partnerships in 2024 and 2025, with broader licensing partnerships anticipated in 2027.

New board additions bring deep venture capital, hardware/software, and robotics experience, with ties to Mithril Capital, Morgan Stanley, Apptronik, NASA, and UT Austin programs.

Neurable completed a December Series A of $35 million to scale commercialization and expand licensing to more consumer devices.

The technology provides metrics such as cognitive readiness and mental states via a companion app, though prior assessments noted verification challenges for algorithm accuracy.

CEO Ramses Alcaide says the aim is to scale widely, moving from targeted partnerships to broad adoption similar to ubiquitous sensors like heart-rate monitors.

Neurable plans to license its noninvasive brain–computer interface (BCI) technology to consumer wearable makers, embedding EEG-enabled AI into devices like headsets, glasses, hats, and headbands to enable mind-reading style controls.

The licensing push aims to scale cognitive-enabled products across industries including consumer tech, gaming, health, defense, and clinical applications, with OEMs customizing design and user experience while leveraging Neurable’s AI-powered brain-sensing tech.

Industry context shows the cognitive wearables market growing from billions in the mid-2020s toward a multi-decade expansion, underscoring a substantial opportunity for scalable BCI integration.

Neurable already has active partnerships across sectors, including with HP Inc.’s HyperX, MeSpace, iMotions, and the U.S. Air Force Research Laboratory.

Key existing collaborations highlighted include collaborations with HP Inc.’s HyperX, MeSpace, iMotions, and the AFRL, signaling broad deployment across consumer, research, and defense domains.

Neurable provides multiple online resources including its website and partner pages, along with media contact details for further information.

The company emphasizes privacy and data protection, stating that brain data are protected and anonymized, with HIPAA-like standards to ensure security and encryption.